Cargando…

Developing an upstream process for a monoclonal antibody including medium optimization

Detalles Bibliográficos
Autores principales:	Duvar, Sevim, Hecht, Volker, Finger, Juliane, Gullans, Matthias, Ziehr, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980829/ http://dx.doi.org/10.1186/1753-6561-7-S6-P34

Ejemplares similares

Feeding strategy optimization in interaction with target seeding density of a fed-batch process for monoclonal antibody production
por: Clincke, Marie-Françoise, et al.
Publicado: (2013)

Technological and methodical process integration in manufacturing of monoclonal antibodies
por: Gronemeyer, Petra, et al.
Publicado: (2015)

Novel monoclonal antibodies against pathogenic Leptospira
por: de Matos, Bruno Moisés, et al.
Publicado: (2014)

2D fluorescence spectroscopy for real-time aggregation monitoring in upstream processing
por: Schwab, Karen, et al.
Publicado: (2013)

Scale-up considerations for monoclonal antibody production process: an oxygen transfer flux approach
por: Gimenez, Laura, et al.
Publicado: (2013)

Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
por: Natrah, MS, et al.
Publicado: (2012)

Rapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
por: Vega, Arantza, et al.
Publicado: (2014)

Amelioration of joint inflammation by a PAR-2-specific monoclonal antibody
por: King, V, et al.
Publicado: (2005)

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

Partial characterization of two novel monoclonal antibodies for Listeria spp. Immunodetection
por: Moreira, Gustavo, et al.
Publicado: (2014)

Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin
por: Higaki, Jeffrey N, et al.
Publicado: (2015)

Regulatory role of upstream AUG codons within the SIVmac239 genome
por: van der Velden, Gisela J, et al.
Publicado: (2011)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
por: Isaacs, JD, et al.
Publicado: (2005)

Monoclonal antibodies that recognize important functional elements of the HIV-1 integrase enzyme
por: Maroun, Richard G, et al.
Publicado: (2012)

The optimization of a rapid low-cost alternative of large-scale medium sterilization
por: Monteil, Dominique T, et al.
Publicado: (2013)

A monoclonal antibody against HIV Tat attenuates neurotoxicity via glutamate receptors
por: Rumbaugh, Jeffrey, et al.
Publicado: (2006)

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection
por: Chen, W, et al.
Publicado: (2009)

Development and implementation of a global Roche cell culture platform for production of monoclonal antibodies
por: Tröbs, Thomas, et al.
Publicado: (2013)

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors
por: Gong, Jian, et al.
Publicado: (2014)

Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy
por: Makkouk, Amani, et al.
Publicado: (2015)

A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design
por: Chen, Y, et al.
Publicado: (2012)

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody
por: Boyerinas, Benjamin, et al.
Publicado: (2014)

Oncogenic signaling upstream of mTORC1 drives lipogenesis and proliferation through SREBP
por: Ricoult, Stéphane, et al.
Publicado: (2014)

Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF alpha monoclonal antibodies
por: Moshous, D, et al.
Publicado: (2011)

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
por: Khalil, Danny, et al.
Publicado: (2015)

Poster 1007: Universal allergen particle generation for inhaled allergen challenges in the fraunhofer environmental challenge chamber (ECC)
por: Hohlfeld, Jens M, et al.
Publicado: (2014)

Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera
por: Matsuno, H, et al.
Publicado: (2003)

In vitro characterization of AA71, a potent and selective human monoclonal antibody against CGRP receptor
por: Shi, L, et al.
Publicado: (2013)

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
por: Gong, Jian, et al.
Publicado: (2013)

Differential affects of low glucose on the macroheterogeneity and microheterogeneity of glycosylation in CHO-EG2 camelid monoclonal antibodies
por: Liu, Bo, et al.
Publicado: (2013)

Antagonist properties of monoclonal antibodies to human CD28: role of valency and heavy-chain constant domain
por: Mary, Caroline, et al.
Publicado: (2012)

The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities
por: Bjorck, Pia, et al.
Publicado: (2015)

Identification of the antigen recognized by rHIgM22, a remyelination-promoting human monoclonal antibody
por: Grassi, Sara, et al.
Publicado: (2015)

Optimized platform medium and feed for rCHO cell lines using the CHEF1(® )expression system
por: Paul, William, et al.
Publicado: (2013)

Cell death and immune regulation: in vivo application of a novel agonistic monoclonal antibody for death receptor Fas
por: Yonehara, S
Publicado: (2003)

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
por: Lynch, RM, et al.
Publicado: (2012)

Characterization of conformation-specific, human-derived monoclonal antibodies against TTR aggregates with potential for diagnostic and therapeutic use
por: Michalon, Aubin, et al.
Publicado: (2015)

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients
por: Trivedi, Sumita, et al.
Publicado: (2015)

Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques
por: Hessell, AJ, et al.
Publicado: (2012)

P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
por: Gorny, MK, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kkjm3se75la0ni64b5hq895i80